Skip to contentSkip to Braille Studio

Library / Laws / 116th Congress / House Bills / H.R. 6660

H.R. 6660

To amend the Federal Food, Drug, and Cosmetic Act to require the holders of approved applications for drugs to conduct a risk assessment to identify and evaluate risks to their supply chain and develop, maintain, and implement risk mitigation plans to address such risks, and for other purposes.

Print stageDateSize⠃
Introduced in House2020-05-015.4K⠃⠗⠋